Featured

TIF’s Latest Newsletter Issue Is Out!
Actualités

TIF’s Latest Newsletter Issue Is Out!

Our August 2020 newsletter has just been published! Read about our latest updates, including country activities, international projects, educational updates for patients with thalassaemia and haemoglobin disorders, and our novel…
Revisiting The Use and Management of Blood in Europe in Times of Crisis and Beyond
Actualités

Revisiting The Use and Management of Blood in Europe in Times of Crisis and Beyond

About 25 million blood transfusions are administered to patients every year throughout the European Union. What may come to mind to most people when thinking about blood transfusion is acute…
AstraZeneca Resumes Final Stage Trials For Its Covid-19 vaccine After Initial Halt
Actualités

AstraZeneca Resumes Final Stage Trials For Its Covid-19 vaccine After Initial Halt

AstraZeneca Plc and the University of Oxford have resumed the British clinical trials of its Covid-19 vaccine, after the initial suspension over concerns with a participant who fell ill. University…
The  »International Blood Diseases Symposium » Is Just Around The Corner
Actualités

The  »International Blood Diseases Symposium » Is Just Around The Corner

The Turkish Federation of Blood Diseases, Kan Hastalıkları Federasyonu  is joining forces with TIF for the organisation of the  »International Blood Diseases Virtual Symposium », which will be held virtually on…
Coming Up: A TIF Live Webinar on  »Heart Disease in Thalassaemia »
Actualités

Coming Up: A TIF Live Webinar on  »Heart Disease in Thalassaemia »

Tune in with TIF on Tuesday, 15 September 2020, 15:00 EEST, for one of the last webinars from the TIF eThalED series for Healthcare Professionals! The topic to be brought…
AstraZeneca Puts Leading COVID-19 Vaccine Trial On Hold
Actualités

AstraZeneca Puts Leading COVID-19 Vaccine Trial On Hold

The pharmaceutical company AstraZeneca halted large, late-stage global trials of its coronavirus vaccine on Tuesday, because of a serious suspected adverse reaction in a participant. It is not yet known…
AstraZeneca Starts U.S. Final-Stage Trial of Covid-19 Vaccine
Actualités

AstraZeneca Starts U.S. Final-Stage Trial of Covid-19 Vaccine

AstraZeneca Plc has begun final-stage, Phase III trial of its coronavirus vaccine AZD1222 in the U.S., according to the company´s latest statement. Trial centers across the US are recruiting up to 30,000 adults aged 18 years…
IMPORTANT ANNOUNCEMENT: TIF’s Renzo Galanello Fellowship Programme 2020 To Be Rescheduled and Compressed
Actualités

IMPORTANT ANNOUNCEMENT: TIF’s Renzo Galanello Fellowship Programme 2020 To Be Rescheduled and Compressed

Due to some difficulties and restrictions encountered as a result of the COVID-19 pandemic, the Renzo Galanello Fellowship Programme 2020 will not be offered in its full length and as initially…
TIF Has Joined the EASL Patient Organisations Community
Actualités

TIF Has Joined the EASL Patient Organisations Community

TIF is constantly fortifying synergies with influential patient organisations for the benefit of individuals with thalassaemia and other Haemoglobin Disorders. Therefore, we are excited to announce that the Federation has recently joined one…
Bouton retour en haut de la page